The Norris Cotton Cancer Center (NCCC) Molecular Biology Shared Resource Laboratory (MBSR) has been operating since 1995 as a core facility. This core initially was developed within the Cancer Center, but was quickly expanded to provide services to other laboratories with the addition of other sources of support. It has operated as a university cost center since 1997, but remains a central and important shared resource for NCCC investigators, who represent a major proportion of its user base. In 2000, proteomics services were added to this shared resource. In 2007 these were split off as the new Proteomics Shared Resource (PRSR) described separately elsewhere. The MBSR provides state-of-the-art molecular biology support including DMA and RNA oligonucleotide synthesis, DMA sequencing, fragment analysis, traditional and real-time PCR services, and various imaging support services for the NCCC membership. The MBSR also collaborates with the Proteomics, Bioinformatics, Genomics, and Biostatistics Shared Resources in providing seamless support for the investigator who is applying these tools for genomic level analyses as part of the Integrative Biology Group (IBG). The MBSR currently provides 54 NCCC members and their laboratories with services which totaled $131 K in chargebacks for FY 2007 ($273K total chargebacks). The NCCC users represented 47% of the total laboratories using this facility at Dartmouth (116 labs total), and their usage constituted 48% of the total usage based on chargeback fees and 44% based on units of use. The total chargebacks for this core were $273 K for FY 2007, and the total operating budget was $597K, requiring $324K in subvention which was derived from the NCCC Core Grant ($57K) and other institutional resources ($267K). This shared resource is requesting a budget of $52,787 from the NCCC Core Grant for the first year of this renewal, representing a level comparable to the current year's support and representing approximately 14% of its total operating budget for FY 2009 of approximately $378K (note that the decrease in subvention support and total budget is due to the splitting of MBSR and PRSR and concomitant reduction in services, costs, and staffing for MBSR). The MBSR continues to add and upgrade instrumentation, including recent upgrades to its DNA sequencing services. It plans to add the new Solexa technology from Agilent in the near future, which will facilitate important laboratory research and allow the NCCC investigators to comprehensively analyze the genetic polymorphisms for the entire genomes of individual cancer patients and thereby provide a means of customizing individual diagnosis and treatment. The overall goal of the MBSR is to continue to provide NCCC researchers with state-of-the-art technical support and services for their cancer research at as low a rate as possible so that they can continue to successfully meet their research objectives individually and collectively.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA023108-31
Application #
7944663
Study Section
Subcommittee G - Education (NCI)
Project Start
2009-04-21
Project End
2013-11-30
Budget Start
2009-04-21
Budget End
2009-11-30
Support Year
31
Fiscal Year
2009
Total Cost
$72,844
Indirect Cost
Name
Dartmouth College
Department
Type
DUNS #
041027822
City
Hanover
State
NH
Country
United States
Zip Code
03755
Durand, Marie-Anne; Yen, Renata West; O'Malley, A James et al. (2018) What matters most: protocol for a randomized controlled trial of breast cancer surgery encounter decision aids across socioeconomic strata. BMC Public Health 18:241
Soneji, Samir S; Sung, Hai-Yen; Primack, Brian A et al. (2018) Quantifying population-level health benefits and harms of e-cigarette use in the United States. PLoS One 13:e0193328
Tosteson, Anna N A; Yang, Qian; Nelson, Heidi D et al. (2018) Second opinion strategies in breast pathology: a decision analysis addressing over-treatment, under-treatment, and care costs. Breast Cancer Res Treat 167:195-203
Molodtsov, Aleksey; Turk, Mary Jo (2018) Tissue Resident CD8 Memory T Cell Responses in Cancer and Autoimmunity. Front Immunol 9:2810
Courtney, Andrea L; Rapuano, Kristina M; Sargent, James D et al. (2018) Brain Reward Responses Are Behaviorally Relevant: The Authors Respond. J Stud Alcohol Drugs 79:41-42
Rutter, Carolyn M; Kim, Jane J; Meester, Reinier G S et al. (2018) Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study. Cancer Epidemiol Biomarkers Prev 27:158-164
Lin, Anping; Yin, Juan; Cheng, Chao et al. (2018) Decreased expression of FOXA2 promotes eutopic endometrial cell proliferation and migration in patients with endometriosis. Reprod Biomed Online 36:181-187
Elder, David E; Piepkorn, Michael W; Barnhill, Raymond L et al. (2018) Pathologist characteristics associated with accuracy and reproducibility of melanocytic skin lesion interpretation. J Am Acad Dermatol 79:52-59.e5
Pernas, Sonia; Martin, Miguel; Kaufman, Peter A et al. (2018) Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial. Lancet Oncol 19:812-824
Kumar, Nishant; Tafe, Laura J; Higgins, John H et al. (2018) Identifying Associations between Somatic Mutations and Clinicopathologic Findings in Lung Cancer Pathology Reports. Methods Inf Med 57:63-73

Showing the most recent 10 out of 1911 publications